Reportlinker Adds the Worldwide Over-the-Counter (OTC) Drug Market

NEW YORK, May 12 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Worldwide Over-the-Counter (OTC) Drug Market

http://www.reportlinker.com/p0196560/The-Worldwide-Over-the-Counter-OTC-Drug-Market.html

Over-the-Counter (OTC) drugs are non-prescription drugs sold to consumers by convenience and grocery stores. These drugs include pain relievers, cough and cold remedies, sleeping aids, antifungals, and other products approved for use as a self-medication product. There has been a particular focus in the pharmaceutical industry on OTC drugs, and in several market research reports over the past decade, Kalorama Information has covered the strategies pharmaceutical companies are using in the OTC market. This report, The Worldwide Over the Counter (OTC) Drug Market has market sizes and forecasts in five general segments:

• Analgesics

• Allergy, Cough, Cold, Flu Remedies

• Gastrointestinal Remedies

• Dermatologics

• Others, including
  • Smoking Cessation Products
  • Sleep Aids
  • Hair Growth Remedies
  • Diet Aids

Revenues for each segment were generated using dollar and unit sales for key products in each segment and region. The report provides examples of OTC drugs in each general region, segmented as follows:

• Asia Pacific and Africa

• Europe

• North America

• South America

Issues and trends explored in this study include:

• Mergers and Acquisitions

• Distribution and Safety Issues

• Consumer Advertising and Promotion

• Demographics

• World Health and Life Expectancy Trends

• Prescription vs. OTC Industry

• Rx-to-OTC Switch Industry

• Economic Trends

• Health Insurance Issues and Trends

• Consumer Issues and Trends

• Regulatory Environment

• Access to Medicine

The report includes incidence of conditions which are often treated with OTC medicines, health statistics related to the industry, birth rates, world population, populations by region and issues affecting the market as a whole. Information is presented as a worldwide overview, with special emphasis on the U.S., Japan, Germany, and other key markets. The market segments provide an overview of demographics, information about products available in each region, market estimates and forecasts. Additionally, a competitive analysis of leading providers and profiles of providers is covered.

In-depth profiles are included for the following companies:

• Bayer Consumer Health

• Boehringer Ingelheim

• GlaxoSmithKline

• McNeil Consumer (Johnson & Johnson)

• Merck/Schering-Plough

• Novartis Pharmaceuticals

• Pfizer/Wyeth Consumer

• Procter & Gamble

• Reckitt Benckiser

• Sanofi-Aventis

• Taisho Pharmaceutical

• Takeda

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 100 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers' level. The base year for data was 2009. Historical data was provided for the years 2007 and 2008, with forecast data provided for 2010 through 2014. Compound annual growth rates (CAGRs) are provided for the 2007-2009 and 2009-2014 periods for each region and/or segment covered. Competitive analysis is provided for the year 2009. The forecasted market analysis for 2009-2014 was largely based on demographic trends, new developments, and global expansion.

CHAPTER ONE: EXECUTIVE SUMMARY

Background

Scope and Methodology

Size and Growth of the Market

Key Issues and Trends Affecting Market

Leading Competitors

CHAPTER TWO: INTRODUCTION

Background

Distribution and Safety Issues in the United States

Consumer Advertising/Promotion

World Health and Life Expectancy

Life Expectancy

Birth Rates

Tobacco Use

Obesity

Declining Growth of the World Population

Prescription VS Over-the-Counter Industry

Rx-to-OTC Switch Industry

Rx-to-OTC Switch Forecast in the United States

Economic Trends

Purchasing Power Trends

U.S. Healthcare Market

U.S. Healthcare Challenges

Health Insurance Issues and Trends

Consumer Issues and Trends

U.S. Consumers

Consumers around the World

Access to Professional Medical Services and the Link to Self-Medication

Regulatory Environment

Revisions to Pharmaceutical Affairs Law (PAL) in Japan

Russian Beneficiary Drug Provision Program

A Third Class of Drugs in the United States

CHAPTER THREE: OTC MARKETS IN ASIA-PACIFIC AND AFRICA

Overview

Demographics

OTC Product Segments

Market Analysis

OTC Product Segment Market Analysis

Markets by Country

CHAPTER FOUR: OTC MARKETS IN EUROPE

Overview

Demographics

OTC Product Segments

Market Analysis

OTC Product Segment Market Analysis

Markets by Country

CHAPTER FIVE: OTC MARKETS IN NORTH AMERICA

Overview

Demographics

OTC Product Segments

Market Analysis

OTC Product Segment Market Analysis

Markets by Country

CHAPTER SIX: OTC MARKETS IN SOUTH AMERICA

Overview

Demographics

OTC Product Segments

Market Analysis

OTC Product Segment Market Analysis

Markets by Country

CHAPTER SEVEN: SUMMARY OF WORLD OTC MARKETS

Overview

OTC Product Segment Market Analysis

Markets by Country

CHAPTER EIGHT: LEADING OTC MANUFACTURERS

Overview

Competitor Analysis

Significant Mergers and Acquisitions

Sanofi-Aventis and Chattem Consumer

Schering-Plough and Merck & Co.

Wyeth and Pfizer

Bristol-Myers Squibb and Novartis AG

Johnson & Johnson and Pfizer

Bayer and Roche

Reckitt Benckiser and Adams Respiratory Therapeutics

Reckitt Benckiser and Boots Healthcare

Leading Corporate Profiles

Bayer Healthcare AG

Boehringer Ingelheim GMBH

Glaxo Smith Kline

Mc Neil Consumer

Merck/Schering-Plough

Novartis Consumer

Pfizer/Wyeth

Procter & Gamble

Reckitt Beckiser

Sanofi-Aventis/Chattem

Taisho Pharmaceutical

Takeda Pharmaceutical

APPENDIX

LIST OF MAJOR COMPANIES

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Table 1-1: Total World OTC Market Analysis, 2005-2014

Figure 1-1: Total World OTC Market Analysis: 2005-2014

CHAPTER TWO: INTRODUCTION

Table 2-1: Average Life Expectancy in Years by Country 1980, 2004 and 2009

Table 2-2: Crude Birth Rate per 1,000 Persons 2000, 2005 and Projected 2010

Figure 2-1: Crude Birth Rate per 1,000 Persons 2000, 2005 and Projected 2010

Table 2-3: Percent of Smokers by Country

Figure 2-2: Average Percent of Smokers Worldwide in Developed Regions

Table 2-4: Percent of Obese* Population, 2006

Table 2-5: World Population 1980 to 2050

Figure 2-3: World Population 1980 to 2050

Table 2-6: Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Country, 2009

Figure 2-4: Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Country, 2009

Table 2-7: Leading FDA Approved Rx-to-OTC Switches, 1994-2009

Figure 2-5: Number of New Rx-to-OTC Switches in the United States, per Year 1976-2009

Table 2-8: Potential Rx-to-OTC Switches, 2010-2014

Table 2-9: Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000 and 2006

Figure 2-6: Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000, and 2006

Table 2-10: Gross National Income Comparison by Country 2000-2005

Figure 2-7: Gross National Income Growth by Country 2000-2005

Table 2-11: National Healthcare Expenditures in the United States 1960-2015

Figure 2-8: Healthcare Spending as a Percent of GDP in the United States

Table 2-12: Health Insurance Trends in the United States 2003-2007

Figure 2-9: Typical Pharmacist-Consumer OTC Drug Counseling Session

CHAPTER THREE: OTC MARKETS IN ASIA-PACIFIC AND AFRICA

Table 3-1: Total Midyear Population by the Five Most Populated Countries in Asia-Pacific, 2005-2025

Figure 3-1: Total Midyear Population by the Five Most Populated Countries in Asia-Pacific, 2005, 2015, and 2025

Table 3-1: Total Midyear Population in Africa by Region, 1995-2025

Figure 3-2: Total Midyear Population for Africa by Region, 2005, 2015, and 2025

Table 3-6: Examples of Marketed OTC Products in Asia-Pacific and Africa (Product Name by Type and Marketer)

Table 3-7: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2009 and 2014

Figure 3-5: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2009

Figure 3-6: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2014

Table 3-8: Asia-Pacific/Africa OTC Market Analysis, 2005-2014

Figure 3-7: Asia-Pacific/Africa OTC Market Analysis: 2005-2014

Table 3-10: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2005-2014

Figure 3-8: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2005-2014

Figure 3-9: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2009

Table 3-12: Asia-Pacific/Africa OTC Market Analysis by Selected Country, 2009

Figure 3-10: Asia-Pacific/Africa OTC Market Analysis by Selected Country, 2009

CHAPTER FOUR: OTC MARKETS IN EUROPE

Table 4-1: Total Midyear Population by the Five Most Populated Countries in Europe, 2005-2009

Figure 3-1: Total Midyear Population by the Five Most Populated Countries in Europe, 2005, 2015, and 2025

Table 4-4: Examples of Marketed OTC Products in Europe (Product Name by Type and Marketer)

Table 4-5: European OTC Market as a Percentage of World Market, 2009 and 2014

Figure 4-3: European OTC Market as a Percentage of World Market, 2009

Figure 4-4: European OTC Market as a Percentage of World Market, 2014

Table 4-6: European OTC Market Analysis, 2005-2014

Figure 4-5: European OTC Market Analysis: 2005-2014

Table 4-8: European OTC Market Analysis, Markets by Product Segment, 2005-2014

Figure 4-6: European OTC Market Analysis, Markets by Product Segment, 2005-2014

Figure 4-7: European OTC Market Analysis by Product Segment, 2009

Table 4-10: European OTC Market Analysis by Selected Country, 2009

Figure 4-8: European OTC Market Analysis by Selected Country, 2009

CHAPTER FIVE: OTC MARKETS IN NORTH AMERICA

Table 5-1: Total Midyear Population by the Five Most Populated Countries in North America, 2005-2025

Figure 5-1: Total Midyear Population by the Five Most Populated Countries in North America, 2005, 2015, and 2025

Table 5-4: Examples of Marketed OTC Products in North America (Product Name by Type and Marketer

Table 5-5: North American OTC Market as a Percentage of World Market, 2009 and 2014

Figure 5-3: North American OTC Market as a Percentage of World Market, 2009

Figure 5-4: North American OTC Market as a Percentage of World Market, 2014

Table 5-6: North American OTC Market Analysis, 2005-2014

Figure 5-5: North American OTC Market Analysis: 2005-2014

Table 5-8: North American OTC Market Analysis by Product Segment, 2005-2014

Figure 5-6: North American OTC Market Analysis by Product Segment, 2005-2014

Figure 5-7: North American OTC Market Analysis by Product Segment, 2009

Table 5-10: North American OTC Market Analysis by Selected Country, 2009

Figure 5-8: North American OTC Market Analysis by Selected Country, 2009

CHAPTER SIX: OTC MARKETS IN SOUTH AMERICA

Table 6-1: Total Midyear Population by the Five Most Populated Countries in South America, 2005-2025

Figure 6-1: Total Midyear Population by the Five Most Populated Countries in South America, 2005, 2015, and 2025

Table 6-4: Examples of Marketed OTC Products in South America (Product Name by Type and Marketer)

Table 6-5: South American OTC Market as a Percentage of World Market, 2009 and 2014

Figure 6-3: South American OTC Market as a Percentage of World Market, 2009

Figure 6-4: South American OTC Market as a Percentage of World Market, 2014

Table 6-6: South American OTC Market Analysis, 2005-2014

Figure 6-5: South American OTC Market Analysis: 2005-2014

Table 6-8: South American OTC Market Analysis by Product Segment, 2005-2014

Figure 6-6: South American OTC Market Analysis by Product Segment, 2005-2014

Figure 6-7: South American OTC Market Analysis by Product Segment, 2009

Table 6-10: South American OTC Market Analysis by Selected Country, 2009

Figure 6-8: South American OTC Market Analysis by Selected Country, 2009

CHAPTER SEVEN: SUMMARY OF WORLD OTC MARKETS

Table 7-1: Total World OTC Market Analysis, 2005-2014

Figure 7-1: Total World OTC Market Analysis: 2005-2014

Table 7-3: Total World OTC Market Analysis, Markets by Product Segment, 2005-2014

Figure 7-2: Total World OTC Market Analysis, Markets by Product Segment, 2005-2014

Figure 7-3: Total World OTC Market Analysis by Product Segment, 2009

Figure 7-4: Total World OTC Market Analysis by Product Segment, 2014

Table 7-5: Top Ten World OTC Markets by Country, 2009

Figure 7-5: Top Ten World OTC Markets by Country, 2009

CHAPTER EIGHT: LEADING OTC MANUFACTURERS

Table 8-1: Leading Suppliers Shares of the OTC Market by Estimated Revenues—2007, 2008, and 2009

Figure 8-1: Leading Suppliers Shares of the OTC Market, 2007

Figure 8-2: Leading Suppliers Shares of the OTC Market, 2008

Figure 8-3: Leading Suppliers Shares of the OTC Market, 2009

To order this report:

Over-The-Counter Drug Industry: The Worldwide Over-the-Counter (OTC) Drug Market

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

SOURCE Reportlinker